Methotrexate and Interstitial Lung Disease
To the Editor We commend Shah et al1 for their recent study, which highlights that treating dermatomyositis with methotrexate does not significantly increase the risk of incident interstitial lung disease (ILD).
Authors
- Davinder Parsad (ORCID: https://orcid.org/0000-0003-0348-0815)
- Surender Singh (ORCID: https://orcid.org/0000-0002-7996-8588)
- Anuradha Bishnoi (ORCID: https://orcid.org/0000-0002-1165-1103)
Institutions
- St. Vincent Hospital (US)
- Post Graduate Institute of Medical Education and Research (IN)
Publication Details
- Journal
- JAMA Dermatology
- Published
- 2024-12-23
- DOI
- https://doi.org/10.1001/jamadermatol.2024.5564
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00